NCT05942885Recruiting
Hypnosis: a Path to Appeasement
Source: ClinicalTrials.gov · Last updated 11 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Hypnosis is a technique allowing the patient to focus his mental attention on a thought or a sensation, with the aim of reducing or modulating the intensity of a negative feeling or an ordeal encountered during the course of treatment. This tool can be used when patients are faced with chronic disorders (pain, anxiety, ...) or iatrogenic effects (nausea, asthenia, ...). The patient is referred to hypnosis care by the doctor, psychologist or paramedics who follow him, when they detect a need. Several scientific studies have shown the effectiveness of hypnosis in improving the quality of life of patients with breast cancer and in reducing pain during invasive procedures. On the other hand, in hematology, no research has measured the evolution of anxiety, over time, in patients receiving hypnotherapy.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- First submitted
- 3 Jul 2023
- Start date
- 30 Oct 2023
- Primary completion date
- 30 Apr 2026
- Lead sponsor
- Hospices Civils de Lyon
- Diseases
- Follicular lymphoma
- NCT number
- NCT05942885
What you commit to
- Study type: Interventional
- Planned participants: 50
- From 30 Oct 2023 to the primary completion date, 30 Apr 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Persons deprived of their liberty by a judicial or administrative decision
- Adults subject to a legal protection measure
Who the study is looking for
- Patients over 18 years old, fluent in French.
- Patients starting hypnotherapy for anxiety disorders.
- Anxiety score on the HADS scale (Hospital Anxiety and Depression Scale) greater than or equal to 8/21
- Patients with diffuse large cell B-cell lymphoma or follicular lymphoma, whatever the stage of the disease.
- Diagnosis announcement less than 2 months old
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Service MB1 - Hôpital Lyon Sud - HCL Coordinator of this site? Confirm its status | Lyon | France | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.